Mangalam Organic
Mangalam Organic Q1 FY27: Revenue ₹179.09 Cr, PAT ₹7.27 Cr
Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.
Based on Mangalam Organic's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q1 FY27 Revenue from Operations: ₹179.09 Cr, up 22.20% YoY from ₹146.55 Cr in Q1 FY26 (Page 10, 11). Q1 FY27 Financials: - EBITDA: ₹22.21 Cr, up 2.82% YoY from ₹21.6 Cr in Q1 FY26.
From Mangalam Organic's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Q1 FY27 Revenue from Operations: ₹179.09 Cr, up 22.20% YoY from ₹146.55 Cr in Q1 FY26 (Page 10, 11).
- Q1 FY27 Gross Profit: ₹76.13 Cr, up 12.74% YoY (Page 11).
- Q1 FY27 EBITDA: ₹22.21 Cr, up 2.82% YoY (Page 11).
- Q1 FY27 PAT: ₹7.27 Cr, down 40.56% YoY (Page 10).
- FY26 Revenue: ₹622.57 Cr, up 17.46% YoY from ₹530.01 Cr in FY25 (Page 9).
- The company does mention a strategic focus on:
- Expanding distribution network to penetrate 14 states.
2 more points from Mangalam Organic's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Mangalam Organic said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points from Mangalam Organic's call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Mangalam Organic said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Mangalam Organic — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Dec 2025 (Q3 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹164 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Mangalam Organic's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Devson Catalyst Ltd (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
- Thirumalai Chemicals Ltd (Q1 FY27)
Consolidated Revenue from Operations: INR 547 Cr (22% YoY increase from INR 450 Cr in Q1 FY26) . Key investor presentation takeaways from Thirumalai Chemicals L
- Neochem Bio Solutions Ltd (Q1 FY27)
Revenue from Operations in H2 FY26: ₹64.9 crore . Key investor presentation takeaways from Neochem Bio's Q1 FY27 investor presentation — and how it ranks agains
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Mangalam Organic and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Mangalam Organic Q1 FY27 results?
Q1 FY27 Revenue from Operations: ₹179.09 Cr, up 22.20% YoY from ₹146.55 Cr in Q1 FY26 (Page 10, 11). Q1 FY27 Financials: - EBITDA: ₹22.21 Cr, up 2.82% YoY from ₹21.6 Cr in Q1 FY26.
What is Mangalam Organic share price analysis?
Mangalam Organic currently shows a neutral. The stock trades at a P/E of 15.8 with a market cap of ₹370 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Mangalam Organic on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
